Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate

Background: Patients with chronic obstructive pulmonary disease (COPD) and suboptimal peak inspiratory flow rate (sPIFR) may not benefit optimally from dry powder inhalers (DPI) because of inadequate inspiratory flow. Nebulized bronchodilators may provide a better alternative. We compared bronchodil...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Chronic Obstr Pulm Dis
Glavni autori: Mahler, Donald A., Ohar, Jill A., Barnes, Chris N., Moran, Edmund J., Pendyala, Srikanth, Crater, Gelnn D.
Format: Artigo
Jezik:Inglês
Izdano: COPD Foundation Inc 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006701/
https://ncbi.nlm.nih.gov/pubmed/31647854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.4.2019.0137
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items